Latest filing published 29 Oct 2021 for Aura Biosciences, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -4.7%Entry US$390.30 · Close at T+365 US$372.15
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Christopher Brett Primiano: trading record in brief
This profile gathers the share dealings of Christopher Brett Primiano across 2 companies, led by Karyopharm Therapeutics Inc. and Aura Biosciences, Inc. We count 49 filings; the first trade dates from 13 May 2014 and the latest from 28 October 2021.
Both buying and selling appear: 1 purchase worth €20k, against 31 sales worth €4.5M. Sales outweigh purchases by €4.5M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 share grant and 16 option exercises.
The record was last updated on 29 October 2021 with a share grant in Aura Biosciences, Inc. The last purchase on record was published on 13 May 2014, which is 4,562 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Christopher Brett Primiano
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,750 shares0Common StockSEC:0000899243-21-042078:0
- 78,124 shares@ US$10.45Common StockSEC:0001209191-20-061537:0
- 78,124 shares@ US$17.66Common StockSEC:0001209191-20-061537:1
- 58,937 shares@ US$10.39Common StockSEC:0001209191-20-061537:2
- 58,937 shares@ US$17.35Common StockSEC:0001209191-20-061537:3
- 772 shares@ US$14.92Common StockSEC:0001209191-20-056883:0
- 38,550 shares@ US$9.21Common StockSEC:0001209191-20-054825:0
- 38,550 shares@ US$16.85Common StockSEC:0001209191-20-054825:1
- 721 shares@ US$10.39Common StockSEC:0001209191-20-054825:2
- 721 shares@ US$17.20Common StockSEC:0001209191-20-054825:3
- 10,054 shares@ US$6.5475.9% of flowCommon StockSEC:0001209191-20-049920:0
- 10,054 shares@ US$14.98Common StockSEC:0001209191-20-049920:1
- 2,946 shares@ US$6.5417.2% of flowCommon StockSEC:0001209191-20-028268:1
- 6,714 shares@ US$19.62Common StockSEC:0001209191-20-028268:0
- 2,946 shares@ US$20.00Common StockSEC:0001209191-20-028268:2
- 26,500 shares@ US$10.39Common StockSEC:0001209191-20-016416:0
- 7,500 shares@ US$23.50Common StockSEC:0001209191-20-016416:1
- 10,000 shares@ US$28.00Common StockSEC:0001209191-20-016416:2
- 9,000 shares@ US$24.00Common StockSEC:0001209191-20-016416:3
- 2,961 shares@ US$16.48Common StockSEC:0001209191-20-011692:0
- 9,675 sharesCommon StockSEC:0001209191-20-010750:0
- 5,000 shares@ US$10.39Common StockSEC:0001209191-19-062196:0
- 5,000 shares@ US$20.00Common StockSEC:0001209191-19-062196:1
- 5,000 shares@ US$10.39Common StockSEC:0001209191-19-059914:1
- 5,000 shares@ US$17.46Common StockSEC:0001209191-19-059914:2
25 of 49 declarations
